GO
Loading...

Enter multiple symbols separated by commas

Intellectual Property Patents

More

  • UPDATE 1-InterDigital loses another round in patent fight Wednesday, 18 Feb 2015 | 4:55 PM ET

    InterDigital had sued phone maker Nokia and ZTE Corp over patents used in the phones. Since the suit was filed, Nokia's handset business was purchased by Microsoft Corp. Microsoft was pleased with the decision, said spokesman David Cuddy.

  • ZTE's efforts to collect patent royalties- months ahead of Qualcomm Inc's China antitrust settlement this week, according to people with knowledge of the matter- shows how that deal has already changed the way China's booming smartphone industry does business. As anticipated by ZTE, a key term in the settlement dissolved Qualcomm's cross-licensing...

  • WASHINGTON, Feb 10- The New York Times Co, J.C. Penney Corp and CBS Corp lost a round on Tuesday in a patent fight with Helferich Patent Licensing LLC, which had accused them of infringing on patents for looking at websites on mobile telephones. Between mid-2010 and March 2012, Helferich filed complaints against the New York Times, J.C. Penney Corp, G4 Media LLC, the...

  • WASHINGTON, Feb 10- The New York Times Co, J.C. Penney Corp and CBS Corp lost a round Tuesday in a patent fight with Helferich Patent Licensing, LLC, which had accused them of infringing on patents for looking at websites on mobile telephones. Between mid-2010 and March 2012, Helferich filed complaints against the New York Times, J.C. Penney Corp, G4 Media LLC, the...

  • SAN FRANCISCO, Feb 9- Microsoft and Samsung Electronics Co Ltd have settled a contract dispute over patent royalties, though terms of the settlement are confidential, Microsoft said in a statement on Monday. Microsoft sued Samsung last year in a federal court in New York, accusing Samsung of breaching a collaboration agreement by initially refusing to make...

  • Feb 9- Microsoft and Samsung Electronics Co Ltd have ended their contract dispute over patents, though terms of the settlement are confidential, Microsoft said in a statement on Monday.

  • Feb 6- Symantec Corp, maker of the popular Norton antivirus software, was ordered to pay $17 million in damages on Friday after a federal jury in Delaware found it had violated two patents owned by Intellectual Ventures, a major patent licensing company. The verdict is a blow to Mountain View, Calif.- based Symantec. A Symantec spokesman said the company was pleased...

  • Feb 6- Symantec Corp, maker of the popular Norton antivirus software, was ordered to pay $17 million in damages on Friday after a federal jury in Delaware found it had violated two patents owned by Intellectual Ventures, a major patent licensing company. While a blow to Mountain View, Calif.- based Symantec, the verdict, which also confirmed the validity of the...

  • LLY's quarterly checkup: CEO Friday, 30 Jan 2015 | 7:15 AM ET
    LLY's quarterly checkup: CEO

    John Lechleiter, Eli Lilly CEO, runs through the quarterly numbers and provides insight to products coming off patents, R&D, and new Alzheimer's drugs in the pipeline.

  • Poking the cloud Friday, 23 Jan 2015 | 11:08 AM ET
    Poking the cloud

    Discussing innovation in the cloud computing space, with Jay Walker, Patent Properties chairman.

  • Unlocking America's 2 million patents Friday, 23 Jan 2015 | 11:08 AM ET
    Unlocking America's 2 million patents

    Jay Walker, Patent Properties chairman, discusses the U.S. patent data base and the idea behind the creation of his patent utility, with CNBC's Simon Hobbs.

  • GoPro rebounds slightly after move lower Wednesday, 14 Jan 2015 | 11:08 AM ET
    GoPro rebounds slightly after move lower

    GoPro dropped 12 percent in Tuesday's trading after news Apple was granted a camera patent. Jon Steinberg, Daily Mail North America CEO, and Mike Santoli, Yahoo! Finance senior columnist, provide perspective.

  • Apple camera patent a GoPro threat? Tuesday, 13 Jan 2015 | 5:35 PM ET
    Apple camera patent a GoPro threat?

    GoPro shares are taking a hit on news Apple has been granted a patent for a remote control camera system. Charlie Anderson, Dougherty and Co. senior research analyst, discusses whether this patent presents real competition to GoPro.

  • Analyzing Eli Lilly's drug pipeline Monday, 12 Jan 2015 | 10:15 AM ET
    Analyzing Eli Lilly's drug pipeline

    CNBC's Meg Tirrell speaks to John Lechleiter, Eli Lilly CEO, about the strength and outlook for the health care sector, and what new drugs he's most excited about.

  • Patent risk firm RPX to buy ‘Rockstar’ assets Wednesday, 24 Dec 2014 | 8:08 AM ET
    The U.S. Patent and Trademark Office (USPTO) seal is displayed outside the headquarters in Alexandria, Virginia

    Patent risk management company RPX announced a deal to buy out the bulk of the assets owned by patent consortium Rockstar.

  • Apple to pay $23.6 million for infringing patents Wednesday, 19 Nov 2014 | 10:21 AM ET
    An Apple store in the China Central Mall in Beijing, China

    A jury has told Apple to pay a Texas company $23.6 million for using SkyTel pager technology in its devices without permission, Bloomberg reported.

  • Patent expirations weigh on Merck Monday, 27 Oct 2014 | 9:31 AM ET
    Patent expirations weigh on Merck

    The "Squawk on the Street" crew discusses pressures facing Merck in regards to drugs coming off patent, and the play on pharma companies.

  • Positive for Regeneron: Cramer Friday, 17 Oct 2014 | 9:55 AM ET
    Positive for Regeneron: Cramer

    CNBC's Jim Cramer discusses news Regeneron's drug Eylea for treating diabetic macular edema created significantly greater improvement in visual acuity compared with Lucentis.

  • Beats & Bose settle lawsuit: Report Friday, 10 Oct 2014 | 3:28 PM ET
    Beats & Bose settle lawsuit: Report

    Apple's Beats and Bose have settled their patent infringement dispute, reports CNBC's Julia Boorstin.

  • FDA OKs Merck melanoma drug, 1st in its class Thursday, 4 Sep 2014 | 5:36 PM ET
    An undated product image provided by Merck & Co., shows packaging for its Keytruda cancer drug.

    U.S. regulators granted accelerated approval to Merck's Keytruda drug, a new type of melanoma treatment for patients with advanced melanoma.